You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse-Remitting Multiple Sclerosis (RR-MS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Chisinau, Moldova, Republic of
    Republican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Integrated Digital Solutions in Medical Care of Multiple

    Not yet recruiting
    • Relapsing Remitting Multiple Sclerosis
    • MS Care Platform (icobrain ms and icompanion ms)
    • (no location specified)
    Jul 10, 2023

    Deficient T Regulatory Cell Function in Relapsing Remitting

    Recruiting
    • Relapse Remitting Multiple Sclerosis
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Jun 13, 2022

      Multiple Sclerosis Trial in Amsterdam (MS Sherpa)

      Recruiting
      • Multiple Sclerosis
      • MS Sherpa
      • Amsterdam, Netherlands
        Amsterdam UMC, locatie VUmc
      Nov 4, 2023

      Elevated Factor VIII Related Labs asBiomarker for Incomplete

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • blood tests drawn days 1, 8, 22 and 90 of the study
      • (no location specified)
      Jun 22, 2023

      Microparticle Delivered STING Agonist in Control of Experimental

      Recruiting
      • Relapse Remitting Multiple Sclerosis
      • Blood Draw
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Jan 20, 2023

      Multiple Sclerosis Trial (Natalizumab)

      Not yet recruiting
      • Multiple Sclerosis
      • (no location specified)
      Jun 21, 2023

      Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))

      Active, not recruiting
      • Multiple Sclerosis
      • 7-day Fasting-Mimicking Diet (7-DAY FMD)
      • Genova, Italy
        Ospedale San Martino
      Sep 8, 2023

      Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • West Orange, New Jersey
        Kessler Foundation
      Oct 12, 2022

      Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in

      Active, not recruiting
      • Multiple Sclerosis
      • +2 more
      • Understanding MRI in MS (website)
      • Control website
      • Hamburg, Germany
        University Medical Centre Hamburg-Eppendorf
      Dec 5, 2022

      Multiple Sclerosis (MS) Symptoms

      Recruiting
      • Relapsing Remitting Multiple Sclerosis
        • Louisville, Kentucky
          University of Louisville (recruiting nationwide)
        Dec 13, 2021

        Mechanistic Studies of Teriflunomide in RRMS

        Active, not recruiting
        • Relapsing Remitting Multiple Sclerosis
        • Ann Arbor, Michigan
          University of Michigan
        Jul 27, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Hamburg (web-based intervention programme, web-based information material

        Active, not recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • web-based intervention programme
        • web-based information material offered via the same platform (broca®) in addition to usual care
        • Hamburg, Germany
          Universitätsklinikum Hamburg-Eppendorf
        Jun 21, 2022

        Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)

        Recruiting
        • Multiple Sclerosis (MS)
        • Relapsing Remitting Multiple Sclerosis
        • Cullman, Alabama
        • +14 more
        Dec 13, 2022

        Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

        Active, not recruiting
        • Relapsing Remitting Multiple Sclerosis
        • 3 mg Melatonin
        • 5 mg Melatonin
        • Portland, Oregon
          Providence MS Center
        May 5, 2022

        Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis Relapse Trial in Istanbul (in-vivo Corneal Confocal Microscopy)

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • Multiple Sclerosis Relapse
        • in-vivo Corneal Confocal Microscopy
        • Istanbul, Turkey
          Marmara University
        Jan 20, 2022

        Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

        Recruiting
        • Multiple Sclerosis
        • +5 more
        • Amsterdam, Netherlands
          Amsterdam UMC, location VUmc
        Apr 17, 2023

        Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • +2 more
        • 18F-DPA-714 and 18F-FDG
        • Paris, France
        • +1 more
        Sep 14, 2022

        Relapsing-Remitting Multiple Sclerosis Trial in Columbus (Step Tracking, Water Tracking)

        Active, not recruiting
        • Relapsing-Remitting Multiple Sclerosis
        • Step Tracking
        • Water Tracking
        • Columbus, Ohio
          Department of Psychology, The Ohio State University
        Jan 24, 2022

        Relaxin in Multiple Sclerosis (MS)

        Recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • Blood Draw
        • Lumbar Puncture
        • Portland, Oregon
          Providence MS Center
        Feb 2, 2022

        Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

        Active, not recruiting
        • Relapsing-remitting Multiple Sclerosis
        • Stockholm, Sweden
          Fredrik Piehl
        Apr 8, 2022

        Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

        Active, not recruiting
        • Relapsing Remitting Multiple Sclerosis (RRMS)
        • Pegylated interferon beta-1a
        • Interferon Beta-1A Prefilled Syringe
        • Tehran, Iran, Islamic Republic of
          Sina Hospital
        Feb 5, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Omaha (BrainHQ cognitive training, BrainHQ control games)

        Not yet recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • BrainHQ cognitive training
        • BrainHQ control games
        • Omaha, Nebraska
          University of Nebraska Medical Center
        Apr 22, 2022